UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Teaming up for CAR-T cell therapy

Haematologica (Roma), 2019-12, Vol.104 (12), p.2335-2336

2019

Volltextzugriff (PDF)

Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life

Haematologica (Roma), 2019-02, Vol.104 (2), p.370-379

2019

Volltextzugriff (PDF)

Current treatment options for aggressive non-Hodgkin lymphoma in elderly and frail patients: practical considerations for the hematologist

Therapeutic Advances in Hematology, 2021, Vol.12, p.2040620721996484

2021

Volltextzugriff (PDF)

High-Dose Chemotherapy With Autologous Stem-Cell Transplantation and Hyperfractionated Radiotherapy As First-Line Treatment of Primary CNS Lymphoma

Journal of clinical oncology, 2006-08, Vol.24 (24), p.3865-3870

2006

Volltextzugriff (PDF)

Signaling by small GTPases in the immune system

Immunological reviews, 2007-08, Vol.218 (1), p.92-101

2007

Volltextzugriff (PDF)

Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets

Therapeutic Advances in Neurological Disorders, 2021, Vol.14, p.17562864211019598-17562864211019598

2021

Volltextzugriff (PDF)

Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries

Frontiers in medicine, 2023, Vol.10, p.1128295-1128295

2023

Volltextzugriff (PDF)

Primary murine CD4+ T cells fail to acquire the ability to produce effector cytokines when active Ras is present during Th1/Th2 differentiation

PloS one, 2014-11, Vol.9 (11), p.e112831-e112831

2014

Volltextzugriff (PDF)

Evidence implicating the Ras pathway in multiple CD28 costimulatory functions in CD4+ T cells

PloS one, 2011-09, Vol.6 (9), p.e24931-e24931

2011

Volltextzugriff (PDF)

The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R‐DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL – Results From the Phase‐II STORM Trial

HemaSphere, 2021-10, Vol.5 (10), p.e636-n/a

2021

Volltextzugriff (PDF)

Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis

Haematologica (Roma), 2011-02, Vol.96 (2), p.291-297

2011

Volltextzugriff (PDF)

Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells

Haematologica (Roma), 2013-01, Vol.98 (1), p.31-40

2013

Volltextzugriff (PDF)

Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency

Journal of allergy and clinical immunology, 2011-12, Vol.128 (6), p.1371-1374.e2

2011

Volltextzugriff (PDF)

Case Report: Refusal of an Veno-Arterial Extracorporeal Membrane Oxygenation Due to Malignant Disease? - An Extremely Rare Form of Cardiac Involvement in Acute Myeloid Leukemia

Frontiers in medicine, 2021-02, Vol.8, p.584507

2021

Volltextzugriff (PDF)

Cytokeratin-type intermediate filaments in a gastric myeloid sarcoma: a diagnostic pitfall

Blood, 2016-07, Vol.128 (3), p.460-460

2016

Volltextzugriff (PDF)

Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab

The New England journal of medicine, 2019-04, Vol.380 (17), p.1676-1677

2019

Volltextzugriff (PDF)

Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia

Journal of clinical oncology, 2014-12, Vol.32 (36), p.4134-4140

2014

Volltextzugriff (PDF)

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

Biomarker Insights, 2015-01, Vol.2015 (S3), p.15-23

2015

Volltextzugriff (PDF)

Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is There Still a Role for Autologous Stem Cell Transplantation in the CAR T-Cell Era?

Cancers, 2024-05, Vol.16 (11), p.1987

2024

Volltextzugriff (PDF)

Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level

Blood, 2007-09, Vol.110 (6), p.1982-1988

2007

Volltextzugriff (PDF)

Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies

Annals of hematology, 2004-09, Vol.83 (9)

2004

Volltextzugriff (PDF)

Reduced-Intensity Conditioning Prior Autologous Stem Cell Transplantion in Elderly DLBCL Patients

Blood, 2022-11, Vol.140 (Supplement 1), p.9523-9524

2022

Volltextzugriff (PDF)

Periphere T-Zell-Lymphome: ASCT in der Erstlinienbehandlung

Im Fokus Onkologie, 2015-02, Vol.18 (1-2), p.22-22

2015

Volltextzugriff (PDF)

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

The Lancet (British edition), 2019-12, Vol.394 (10216), p.2271-2281

2019

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(175)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Englisch
(206)
Deutsch
(29)

Erscheinungsjahr

n.n

Thema

Science & Technology
(105)
Life Sciences & Biomedicine
(90)
Humans
(59)
Hematology
(46)
Female
(36)
Male
(35)
Middle Aged
(31)
Oncology
(28)
Adult
(25)
Aged
(24)
Immunology
(18)
Animals
(17)
Treatment Outcome
(17)
Medicine
(16)
Lymphoma
(15)
Mice
(14)
Biological And Medical Sciences
(13)
Medicine & Public Health
(12)
Patients
(12)
Hematopoietic Stem Cell Transplantation
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Teaming up for CAR-T cell therapy

Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life

Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial

Current treatment options for aggressive non-Hodgkin lymphoma in elderly and frail patients: practical considerations for the hematologist

High-Dose Chemotherapy With Autologous Stem-Cell Transplantation and Hyperfractionated Radiotherapy As First-Line Treatment of Primary CNS Lymphoma

Signaling by small GTPases in the immune system

Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tablets

Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries

Primary murine CD4+ T cells fail to acquire the ability to produce effector cytokines when active Ras is present during Th1/Th2 differentiation

Evidence implicating the Ras pathway in multiple CD28 costimulatory functions in CD4+ T cells

The mTOR Inhibitor Temsirolimus Added to Rituximab Combined With Dexamethasone, Cytarabine, and Cisplatinum (R‐DHAP) for the Treatment of Patients With Relapsed or Refractory DLBCL – Results From the Phase‐II STORM Trial

Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis

Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells

Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency

Case Report: Refusal of an Veno-Arterial Extracorporeal Membrane Oxygenation Due to Malignant Disease? - An Extremely Rare Form of Cardiac Involvement in Acute Myeloid Leukemia

Cytokeratin-type intermediate filaments in a gastric myeloid sarcoma: a diagnostic pitfall

Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab

Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms

Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is There Still a Role for Autologous Stem Cell Transplantation in the CAR T-Cell Era?

Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level

Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies

Reduced-Intensity Conditioning Prior Autologous Stem Cell Transplantion in Elderly DLBCL Patients

Periphere T-Zell-Lymphome: ASCT in der Erstlinienbehandlung

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

Suchergebnisse filtern